146 related articles for article (PubMed ID: 37264061)
21. Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes.
St Helen G; Dempsey DA; Havel CM; Jacob P; Benowitz NL
Drug Alcohol Depend; 2017 Sep; 178():391-398. PubMed ID: 28704768
[TBL] [Abstract][Full Text] [Related]
22. Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial.
Foulds J; Cobb CO; Yen MS; Veldheer S; Brosnan P; Yingst J; Hrabovsky S; Lopez AA; Allen SI; Bullen C; Wang X; Sciamanna C; Hammett E; Hummer BL; Lester C; Richie JP; Chowdhury N; Graham JT; Kang L; Sun S; Eissenberg T
Nicotine Tob Res; 2022 Jun; 24(7):955-961. PubMed ID: 34850164
[TBL] [Abstract][Full Text] [Related]
23. Interactive effects of protonated nicotine concentration and device power on ENDS nicotine delivery, puff topography, and subjective effects.
Eversole A; Budd S; Karaoghlanian N; Lipato T; Eissenberg T; Breland AB
Exp Clin Psychopharmacol; 2023 Apr; 31(2):443-454. PubMed ID: 35696157
[TBL] [Abstract][Full Text] [Related]
24. Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes.
D'Ruiz CD; Graff DW; Yan XS
BMC Public Health; 2015 Sep; 15():991. PubMed ID: 26424091
[TBL] [Abstract][Full Text] [Related]
25. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics.
Walele T; Sharma G; Savioz R; Martin C; Williams J
Regul Toxicol Pharmacol; 2016 Feb; 74():187-92. PubMed ID: 26696273
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
Liu J; Wang J; Vansickel A; Edmiston J; Graff D; Sarkar M
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):241-250. PubMed ID: 33502815
[TBL] [Abstract][Full Text] [Related]
27. Electronic Nicotine Delivery System (ENDS) Device Types and Flavors Used by Youth in the PATH Study, 2016-2019.
Gardner LD; Liu ST; Xiao H; Anic GM; Kasza KA; Sharma E; Hyland AJ
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564630
[TBL] [Abstract][Full Text] [Related]
28. A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes.
Chapman F; McDermott S; Rudd K; Taverner V; Stevenson M; Chaudhary N; Reichmann K; Thompson J; Nahde T; O'Connell G
Psychopharmacology (Berl); 2022 Sep; 239(9):2931-2943. PubMed ID: 35732751
[TBL] [Abstract][Full Text] [Related]
29. Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu
Morris P; McDermott S; Chapman F; Verron T; Cahours X; Stevenson M; Thompson J; Chaudhary N; O'Connell G
Intern Emerg Med; 2022 Mar; 17(2):397-410. PubMed ID: 34435305
[TBL] [Abstract][Full Text] [Related]
30. Use of electronic nicotine delivery systems (ENDS) among U.S. women of reproductive age: Prevalence, reported reasons for use, and toxin exposure.
Coleman SRM; Bunn JY; Nighbor TD; Kurti AN; Bolívar HA; Tyndale RF; Higgins ST
Prev Med; 2021 Nov; 152(Pt 2):106582. PubMed ID: 33930436
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System.
Teichert A; Brossard P; Felber Medlin L; Sandalic L; Franzon M; Wynne C; Laugesen M; Lüdicke F
Nicotine Tob Res; 2018 Mar; 20(4):458-465. PubMed ID: 28482017
[TBL] [Abstract][Full Text] [Related]
32. JUUL's 2019 Removal of Mint-Flavored Pods and Changes to the Retail Environment of Electronic Nicotine Delivery Systems in Florida and the United States.
Gaber J; Gammon DG; Lee YO; Nonnemaker J; Young B; Kim A; Porter L
Nicotine Tob Res; 2022 Oct; 24(11):1748-1755. PubMed ID: 35569072
[TBL] [Abstract][Full Text] [Related]
33. Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom.
Goldenson NI; Ding Y; Prakash S; Hatcher C; Augustson EM; Shiffman S
Nicotine Tob Res; 2021 Oct; 23(11):1821-1830. PubMed ID: 34002223
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes.
Picavet P; Haziza C; Lama N; Weitkunat R; Lüdicke F
Nicotine Tob Res; 2016 May; 18(5):557-63. PubMed ID: 26438645
[TBL] [Abstract][Full Text] [Related]
35. A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes.
Ebajemito JK; McEwan M; Gale N; Camacho OM; Hardie G; Proctor CJ
Sci Rep; 2020 Nov; 10(1):19980. PubMed ID: 33235307
[TBL] [Abstract][Full Text] [Related]
36. Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers.
Leventhal AM; Goldenson NI; Barrington-Trimis JL; Pang RD; Kirkpatrick MG
Drug Alcohol Depend; 2019 Oct; 203():99-106. PubMed ID: 31434028
[TBL] [Abstract][Full Text] [Related]
37. Electronic nicotine delivery systems (ENDS) flavours and devices used by adults before and after the 2020 US FDA ENDS enforcement priority: findings from the 2018 and 2020 US ITC Smoking and Vaping Surveys.
Gravely S; Meng G; Hammond D; Reid JL; Seo YS; Hyland A; Cummings KM; Rivard C; Fong GT; Kasza KA
Tob Control; 2022 Nov; 31(Suppl 3):s167-s175. PubMed ID: 36328466
[TBL] [Abstract][Full Text] [Related]
38. Bupropion/zonisamide combination to assist smokers to switch from combustible cigarettes to electronic nicotine delivery systems (ENDS).
Rose JE; Willette PN; Botts TL; Botts DR; Behm FM
Drug Alcohol Depend; 2022 May; 234():109346. PubMed ID: 35306393
[TBL] [Abstract][Full Text] [Related]
39. Changes in Biomarkers of Exposure and Potential Harm in Smokers Switched to Vuse Vibe or Vuse Ciro Electronic Nicotine Delivery Systems.
Kanobe MN; Nelson PR; Brown BG; Chen P; Makena P; Caraway JW; Prasad GL; Round EK
Toxics; 2023 Jun; 11(7):. PubMed ID: 37505530
[TBL] [Abstract][Full Text] [Related]
40. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users.
Wagener TL; Floyd EL; Stepanov I; Driskill LM; Frank SG; Meier E; Leavens EL; Tackett AP; Molina N; Queimado L
Tob Control; 2017 Mar; 26(e1):e23-e28. PubMed ID: 27729564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
